NR3C2 and Dravet syndrome: In this study, eplerenone, a MR antagonist, and hydralazine reduced blood pressure to the similar extent in high-salt-fed DS rats; however, podocyte injury and urine protein excretion were ameliorated only in eplerenone-treated group [25].